Credit Agricole
SBIO icon

Credit Agricole’s ALPS Medical Breakthroughs ETF SBIO Stock Holding History

Credit Agricole’s Portfolio SBIO Stock Details SBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-43,453
Closed -$1.9M – 1558
2017
Q1 		$1.9M Buy
+43,453
New +$1.08M 0.01% 1015

Other funds holding SBIO

UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
RJA
Raymond James & Associates St Petersburg, Florida $164B AUM 33.91% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
CT
Cambridge Trust Cambridge, Massachusetts $2.64B AUM 28.73% 1-Year Est. Return
NAM
NTV Asset Management Charleston, West Virginia $910M AUM 27.02% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Credit Agricole's SBIO Position: Q2 2017 in Review

Credit Agricole sold out of ALPS Medical Breakthroughs ETF (SBIO) in Q2 2017, closing a stake of 43,453 shares — an estimated $1.9M sold.

Credit Agricole first reported a position in SBIO in Q1 2017 and held it in 1 quarter. The position peaked at $1.9M in Q1 2017. 26 funds tracked by Wall St. Rank hold SBIO as of Q2 2017.

  • Credit Agricole reported no remaining ALPS Medical Breakthroughs ETF position as of Q2 2017 after selling out during the quarter.
  • Credit Agricole sold 43,453 ALPS Medical Breakthroughs ETF shares in Q2 2017, an estimated $1.9M.
  • Credit Agricole first reported a position in ALPS Medical Breakthroughs ETF in Q1 2017 and held it in 1 quarter.
  • Credit Agricole's ALPS Medical Breakthroughs ETF position peaked at $1.9M in Q1 2017.
  • 26 funds tracked by Wall St. Rank held ALPS Medical Breakthroughs ETF as of Q2 2017.

Based on Credit Agricole's 13F filing for Q2 2017, filed 14 Aug 2017.